Returning aggregate results of clinical trials: Empirical data of patient preferences
- PMID: 31404276
- PMCID: PMC6676435
- DOI: 10.1017/cts.2018.340
Returning aggregate results of clinical trials: Empirical data of patient preferences
Abstract
Introduction: The purpose of this research was to understand the preferences of patients receiving integrative medicine services for return of aggregate study results.
Methods: A brief online survey (survey 1) was sent to 341 cancer patients receiving integrative medicine interventions; subsequently, a minimally revised survey (survey 2) was sent to 812 individuals with various medical conditions who had been either research participants in integrative medicine studies (n = 446) or patients (n = 346) of mind-body medicine.
Results: Feedback to a model plain language summary was elicited from survey 1 and survey 2 respondents. Seventy-seven survey recipients (23%) responded to survey 1, and 134 survey recipients (17%) responded to survey 2. The majority of respondents to the surveys were female and 51-70 years of age. Ninety percent of responders to survey 1 and 89% of responders to survey 2 indicated that researchers should share overall results of a study with participants. In terms of the means of result distribution, 37%-47% preferred email, while 22%-27% indicated that, as long as the results are shared, it did not matter how this occurred. Of 38 survey 1 respondents who had previously participated in a clinical trial, 37% had received the results of their study. In survey 2, 63 individuals indicated that they previously participated in clinical trials, but only 16% recalled receiving results.
Conclusions: These results confirm that the majority (89%-90%) of integrative medicine patients are interested in receiving the results of clinical trials. The majority (82%-94%) of respondents felt the model plain language summary of results provided was helpful.
Keywords: Clinical trial; cancer; integrative medicine; lay summaries; plain language; return of results; transparency.
Figures
References
-
- Lunshof JE, Church GM, Prainsack B. Raw personal data: providing access. Science 2014; 343(6169): 373–374. - PubMed
-
- Institute of Medicine (IOM) Committee on Strategies for Responsible Sharing of Clinical Trial Data. Strategies for responsible sharing of clinical trial data, 2015. Retrieved from http://www.nationalacademies.org/hmd/Activities/Research/SharingClinical.... Accessed August 8, 2017.
-
- European Medicines Agency: Science, Medicines, Health. Clinical trial regulation Retrieved from http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/gen.... Accessed August 13, 2017.
-
- European Commission. Summaries of clinical trial results for laypersons. Recommendations of the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use, 2017. Retrieved from https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/201.... Accessed September 9, 2017.
-
- Health Research Authority/NHS. Summary of clinical trial results for laypersons Recommendations of the expert group on clinical trials for the implementation of regulation (EU) No 536/2014 on clinical trials on medicinal products for human use Consultation Response from the Health Research Authority, 2016. Retrieved from http://www.hra.nhs.uk/documents/2016/09/gl3-summary-clinical-trial-resul.... Accessed September 9, 2017.
LinkOut - more resources
Full Text Sources